BRIEF-Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results And Recent Portfolio Execution

Reuters
29 Oct 2024

Oct 29 (Reuters) - Kiniksa Pharmaceuticals Ltd :

* KINIKSA PHARMACEUTICALS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

* KINIKSA PHARMACEUTICALS LTD: EXPECTS 2024 ARCALYST NET PRODUCT REVENUE OF BETWEEN $410 MILLION AND $420 MILLION

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10